uniQure N.V.
Last updated September 27, 2026
Organization details
- Legal name
- uniQure N.V.
- Ownership
- Public
- Status
- Active
- Headquarters country
- Netherlands
- Ticker symbol
- QURE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001590560
Board of directors
-
David D. Meek · DirectorSince 2023
-
Jack Kaye · DirectorSince 2023
-
Jeremy P. Springhorn · DirectorSince 2023
-
Leonard E. Post · DirectorSince 2023
-
Madhavan Balachandran · DirectorSince 2023
-
Matthew C. Kapusta · Director · CEO, Managing DirectorSince 2023
-
Paula Soteropoulos · DirectorSince 2023
-
Rachelle Suzanne Jacques · DirectorSince 2023
-
Robert Gut · DirectorSince 2023
Chief executives
Matthew C. Kapusta
· CEO, Managing Director
Dates unknown
Board connections
6 of this board's directors also sit on 8 other boards.
- via Rachelle Suzanne Jacques
- via Leonard E. Post
- via Rachelle Suzanne Jacques
- via David D. Meek
- via Paula Soteropoulos
- via Jack Kaye
- via Paula Soteropoulos
- via Madhavan Balachandran
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 10, 2024 | Matthew C. Kapusta Director, Officer (CEO, Managing Director) | Option exercise | +100,000 | $14.71 | $1,471,000 |
| Dec 10, 2024 | Matthew C. Kapusta Director, Officer (CEO, Managing Director) | Open-market sale | −100,000 | $15.03 | $1,503,000 |
| Dec 9, 2024 | Matthew C. Kapusta Director, Officer (CEO, Managing Director) | Open-market sale | −3,418 | $7.63 | $26,079 |
| Dec 9, 2024 | KLEMT CHRISTIAN Officer (Chief Financial Officer) | Open-market sale | −1,796 | $7.55 | $13,560 |
| Dec 8, 2024 | Matthew C. Kapusta Director, Officer (CEO, Managing Director) | Grant or award | +10,494 | — | — |
| Dec 8, 2024 | KLEMT CHRISTIAN Officer (Chief Financial Officer) | Grant or award | +3,672 | — | — |
| Jun 26, 2024 | Abi-Saab Walid Officer (Chief Medical Officer) | Open-market sale | −1,447 | $4.36 | $6,309 |
| Jun 19, 2024 | Robert Gut Director | Grant or award | +8,080 | — | — |
| Jun 19, 2024 | Jeremy P. Springhorn Director | Grant or award | +8,080 | — | — |
| Jun 19, 2024 | David D. Meek Director | Grant or award | +8,080 | — | — |
| Jun 19, 2024 | Madhavan Balachandran Director | Grant or award | +8,080 | — | — |
| Jun 19, 2024 | Jack Kaye Director | Grant or award | +8,080 | — | — |
| Jun 19, 2024 | Leonard E. Post Director | Grant or award | +8,080 | — | — |
| Jun 19, 2024 | Rachelle Suzanne Jacques Director | Grant or award | +8,080 | — | — |
| Jun 17, 2024 | CALOZ PIERRE Officer (Chief Operating Officer) | Open-market sale | −2,936 | $4.81 | $14,122 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.